注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Catalent Inc是一家为药物、细胞和基因疗法生物制剂、疫苗和消费者保健产品提供开发和制造解决方案的供应商。该公司的部门包括生物制剂、软胶囊和口服技术、口服和专业递送以及临床供应服务。其生物制品部门为蛋白质、质粒DNA mRNA、细胞疗法、病毒疫苗和基于病毒的基因疗法提供开发和制造。其软胶囊和口服技术部门提供软胶囊的配方、开发和制造服务,以及口服固体剂型的大规模制造。其口服和特殊给药部门提供一系列技术的配方开发和制造,以及集成的下游临床开发和商业供应解决方案。其临床供应服务部门为药物、生物制品和临床试验提供制造、包装、储存、分销和库存管理。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Rolf A. Classon | 78 | 2014 | Independent Director |
Jack L. Stahl | 70 | 2014 | Independent Lead Director |
Gregory T. Lucier | 59 | 2015 | Independent Director |
Alessandro Maselli | 51 | 2016 | President, CEO & Director |
John J. Greisch | 68 | 2018 | Executive Chairman of the Board |
Edward R. Robinson | - | 2015 | Member of Advisory Board |
Donald Eugene Morel | 65 | 2015 | Independent Director |
Michael J. Buckley | 62 | 2015 | Member of Advisory Board |
Carolyn R. Bertozzi | 56 | 2015 | Member of Scientfic & Advisory Board |
Barry C. Buckland | 75 | 2015 | Member of Advisory Board |
Daniel R. Marshak | 66 | 2015 | Member of Advisory Board |
J. Martin Carroll | 74 | 2015 | Independent Director |
Matthew R. Stober | 56 | - | Member of the Biologics Advisory Board |
Steven K. Barg | 60 | 2023 | Independent Director |
David E. Schaffer | 54 | 2019 | Member of the Biologics Advisory Board |
Stephanie Smith Okey | 63 | 2023 | Independent Director |
Michael J. Barber | 63 | 2021 | Independent Director |
Michelle R. Ryan | 57 | 2023 | Independent Director |
Frank A. D'Amelio | 66 | 2023 | Independent Director |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核